Properties
Description
Eglumegad inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets mGluR2R, and mGluR3R.
Molecular Formula
C8H11NO4
Targets
mGluR2R: 5 nM; mGluR3R: 24 nM
Applications
Eglumegad can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.